Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/1999
03/02/1999US5876920 Screening for vircides and viral suppressors by contacting infected cell with agent, determining if suppression of prenylation of proteins; against hepatitis virus
03/02/1999US5876723 Purified human papillomavirus type 33 (HPV-33) peptides as an immunogenic composition
03/02/1999US5876713 Glutamine: fructose-6-phosphate amidotransferase, its production and use
03/02/1999US5876711 Binding of p53 to the second polynucleotide sequence causes the expression of the reporter molecule which can be detected or quantified.
03/02/1999CA2242315A1 Mecb
03/02/1999CA2242252A1 Dexb
03/02/1999CA2241417A1 Novel ffh
03/02/1999CA2214461A1 Screening method for determining individuals at risk of developing diseases associated with different polymorphic forms of wildtype p53
03/01/1999CA2242311A1 Novel compounds
02/1999
02/28/1999CA2241400A1 Ftsy
02/28/1999CA2214233A1 Method for assessing viability of live microbial therapeutic agents
02/27/1999CA2233681A1 Novel div1b
02/26/1999CA2241431A1 Novel spoiiie
02/26/1999CA2241410A1 Pth
02/25/1999WO1999009455A1 Multi parameter scanner
02/25/1999WO1999009410A2 Rapid assay for simultaneous detection and differentiation of antibodies to hiv
02/25/1999WO1999009408A1 Method and device for detecting a condition
02/25/1999WO1999009407A1 Condition detector
02/25/1999WO1999009218A1 Polymorphism detection utilizing clustering analysis
02/25/1999WO1999009217A1 Methods and compositions for detection or quantification of nucleic acid species
02/25/1999WO1999009216A2 Highly sensitive multimeric nucleic acid probes
02/25/1999WO1999009214A1 Antisense oligonucleotide compositions and methods for the modulation of jnk proteins
02/25/1999WO1999009213A1 Methods for dna amplification and kits therefor
02/25/1999WO1999009212A1 Telomerase assay
02/25/1999WO1999009211A1 Amplification of nucleic acids
02/25/1999WO1999009210A2 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection
02/25/1999WO1999009209A1 A method to assay enzymatic covalent bond formation and cleavage
02/25/1999WO1999009208A1 Method and reagent for monitoring apoptosis and distinguishing apoptosis from necrosis
02/25/1999WO1999009207A1 Culture and identification media specific of different species of candida and analysis methods
02/25/1999WO1999009203A1 Chromatographic method for mutation detection using mutation site specifically acting enzymes
02/25/1999WO1999009202A1 Process to detect toxic substances in the environment
02/25/1999WO1999009201A2 Biosensor with immobilized bioluminescent microorganisms
02/25/1999WO1999009199A2 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor
02/25/1999WO1999009186A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
02/25/1999WO1999009183A1 MUTANT α-AMYLASE COMPRISING MODIFICATION AT RESIDUES CORRESPONDING TO A210, H405 AND/OR T412 IN $i(BACILLUS LICHENIFORMIS)
02/25/1999WO1999009182A2 Rab proteins
02/25/1999WO1999009177A2 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus
02/25/1999WO1999009174A1 Genetic control of plant growth and development
02/25/1999WO1999009171A1 Ubc7-like ubiquitin-conjugating enzyme
02/25/1999WO1999009170A1 High affinity immunoglobulin e receptor-like protein
02/25/1999WO1999009168A1 Testis-specific transcription factor zgcl-1
02/25/1999WO1999009166A2 Prostate tumor polynucleotide and antigen compositions
02/25/1999WO1999009165A1 Trail receptors, nucleic acids encoding the same, and methods of use thereof
02/25/1999WO1999009164A1 Coding sequence haplotypes of the human brca2 gene
02/25/1999WO1999009162A2 Delayed progression to aids by a missense allele of the ccr2 gene
02/25/1999WO1999009158A1 PROTEIN HAVING Zn FINGER-LIKE MOTIF
02/25/1999WO1999009157A1 POLYPEPTIDE HAVING A GTPase REGULATOR ACTIVITY, NUCLEIC ACIDS CODING THEREFOR AND THEIR USE IN DIAGNOSTICS AND THERAPY
02/25/1999WO1999009156A2 Protease-related protein
02/25/1999WO1999009155A1 70 human secreted proteins
02/25/1999WO1999009146A1 Human serum inducible kinase (snk)
02/25/1999WO1999009145A1 Identification of sortase gene
02/25/1999WO1999009140A1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
02/25/1999WO1999009138A1 Novel extracellular serine protease
02/25/1999WO1999009054A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
02/25/1999WO1999009049A1 Hypoxia-regulated genes
02/25/1999WO1999009046A1 Hypoxia-regulated genes
02/25/1999WO1999009045A1 Antisense and antigene therapeutics with improved binding properties and methods for their use
02/25/1999WO1999009041A2 Solution phase synthesis of oligonucleotides
02/25/1999WO1999009012A1 Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein
02/25/1999WO1999008717A2 Latent reactive polymers with biologically active moieties
02/25/1999WO1999008539A1 Novel phytase
02/25/1999WO1999008532A1 Control of enterohemorrhagic e. coli o157:h7 in cattle by probiotic bacteria
02/25/1999WO1999008522A1 Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity
02/25/1999WO1999008507A1 Method of directed breeding for reduced reproductive development
02/25/1999WO1998054344A3 Modulators of morphogen expression and methods of identifying the same
02/25/1999WO1998053300A3 System and apparaus for sequential processing of analytes
02/25/1999WO1998053101A3 Methods and composition to identify swine genetically resistant to f18 e. coli associated diseases
02/25/1999WO1998053050A3 Short peptides which selectively modulate the activity of serine/threonine kinases
02/25/1999WO1998049317A3 Diagnosis and treatment of phosphatase- 0r kinase-related disorders
02/25/1999WO1998039485A3 Compositions and methods for analysis of nucleic acids
02/25/1999WO1998037418A3 Compounds for immunodiagnosis of prostate cancer and methods for their use
02/25/1999WO1998033808A3 A reversible stoichiometric process for conjugating biomolecules
02/25/1999WO1998032017A3 Modulators of insulin receptor activity
02/25/1999DE19736691A1 Characterising and identifying disseminated metastatic cancer cells
02/25/1999DE19736366A1 Isolating anionic substances e.g. protein, nucleic acids, from aqueous systems
02/25/1999CA2852463A1 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection
02/25/1999CA2720384A1 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection
02/25/1999CA2301801A1 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor
02/25/1999CA2301796A1 70 human secreted proteins
02/25/1999CA2301724A1 Culture and identification media specific of different species of candida and analysis methods
02/25/1999CA2301374A1 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
02/25/1999CA2301202A1 Trail receptors, nucleic acids encoding the same, and methods of use thereof
02/25/1999CA2301139A1 Antisense oligonucleotide compositions and methods for the modulation of jnk proteins
02/25/1999CA2301138A1 High affinity immunoglobulin e receptor-like protein
02/25/1999CA2301043A1 Testis-specific transcription factor zgcl-1
02/25/1999CA2300964A1 Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity
02/25/1999CA2300940A1 Methods and compositions for detection or quantification of nucleic acid species
02/25/1999CA2300938A1 Antisense and antigene therapeutics with improved binding properties and methods for their use
02/25/1999CA2300918A1 Ubc7-like ubiquitin-conjugating enzyme
02/25/1999CA2300874A1 Solution phase synthesis of oligonucleotides
02/25/1999CA2300805A1 Polypeptide having a gtpase regulator activity, nucleic acids coding therefor and their use in diagnostics and therapy
02/25/1999CA2300801A1 Rab proteins
02/25/1999CA2300477A1 Amplification of nucleic acids
02/25/1999CA2300367A1 Protein having zn finger-like motif
02/25/1999CA2300364A1 Prostate tumor polynucleotide and antigen compositions
02/25/1999CA2300093A1 Delayed progression to aids by a missense allele of the ccr2 gene
02/25/1999CA2299625A1 Polymorphism detection utilizing clustering analysis
02/25/1999CA2299345A1 Multi parameter scanner
02/25/1999CA2298866A1 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
02/25/1999CA2298630A1 Chromatographic method for mutation detection using mutation site specifically acting enzymes